Bavarian Nordic

This study tests a new vaccine to prevent chikungunya, a virus that causes fever and severe joint pain. About 6,144 people aged 12 and older will receive either the vaccine or a placebo. Researchers will check if the vaccine safely prevents infection and reduces long-term joint p…

This study tests a vaccine against chikungunya virus in about 720 children aged 1 to under 12. The vaccine uses virus-like particles to train the immune system. Researchers will check if it is safe and triggers a strong immune response compared to a placebo.